Safety / toxicology 2023

Mortality rate and liver transplant in mushroom poisoning: systematic review and meta-analysis of 33 studies

Systematic review and meta-analysis of 33 studies on mushroom-poisoning mortality: reported case fatality ranged 0–40% across series, pooled estimate 2.87%. Of 16 liver-transplant patients, 14 survived. The worst prognosis is in patients with hepatic and renal involvement; early admission reduces transplant need.

Janatolmakan M., Jalilian M., Rezaeian S., Abdi A., Khatony A. Mortality rate and liver transplant in patients with mushroom poisoning: A systematic review & meta-analysis. Heliyon. 2023;9(1):e12759.

Rationale

Toxicology cards usually quote mortality "from…to" ranges without a sense of the true average. This study is the first attempt to assemble a single estimate across world literature.

Methods

PRISMA review of international databases to 1 March 2022; meta-analysis in CMA. 33 studies reporting mortality and liver transplantation in mushroom poisoning were included.

Results

  • Mortality in individual series: 0–40% — a huge spread by species, region and ICU access.
  • Pooled mortality: 2.87% (across studies reporting at least one death; excluding zero-death series gives 1.4%).
  • Liver transplantation: 16 patients, 14 survived — transplantation genuinely saves lives in amatoxin injury.
  • Worst prognosis: patients with established hepatic and renal involvement — i.e., late presenters.

Authors' conclusions

Mortality from mushroom poisoning is significant; organ involvement marks the highest-risk group; liver transplant is lifesaving, and early admission reduces the need for it.

Worth noting

The 2.87% figure averages highly heterogeneous series (from incidental entoloma poisoning to amatoxin outbreaks). It understates the real risk of amatoxins (10–30%) and overstates mild GI poisonings. The main conclusion echoes Enjalbert and Diaz: time decides everything — the earlier support and detoxification start, the rarer the transplant.